S&P futures are down 0.8% Friday morning following Thursday’s mostly lower finish. The Dow managed a small gain, breaking a 10-day losing streak, while semis and homebuilders underperformed. Big tech was mostly higher. Treasuries firmed with a bull steepening curve, though rates remain higher for the week. The dollar is down 0.2%, gold up 0.3%, […]
ETFsector.com Daily Trading Outlook, December 20, 2024 Read More »
National Bank of Canada FI increased its ownership in Vertex Pharmaceuticals Incorporated by 125.0% during the third quarter as reported in its latest Form 13F filing.
Deeply oversold similar to XLP, but too big an allocation to go long without more evidence of positive change
Healthcare Sector November Outlook—Healthcare stocks are down and out to start November Read More »
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced the initial acceptance of medical presentations regarding the Phase 3 data for the investigational once daily vanzacaftor/tezacaftor/deutivacaftor.
We are near market weight in our XLV allocation for September. Model inputs have improved marginally, but the sustained consolidation in equity prices that typically catalyze performance for the sector have remained elusive
The XLV lost ground by moving sideways in June, unable to entice investors who were looking to add risk instead. The price action has been sideways since XLV peaked in February, and with a weak start to July trading, the pattern is taking on a distributional look.
Northern Trust Corp reduced its investment in Vertex Pharmaceuticals Incorporated by 4.7% in the 4th quarter, as disclosed in its latest filing.
Northern Trust Corp has reduced its holding in Vertex Pharmaceuticals Incorporated. Read More »
In 2024, the same trends from the previous year have continued, with megacap companies propelling the S&P 500 and Nasdaq Composite to record highs.
5 best stocks to purchase in June Read More »
You are likely aware of the saying “April showers bring May flowers,” as well as the joke about what May flowers bring.
3 Simple Stocks to Purchase in June Read More »
The stock market has been doing relatively well since the start of the year, but there is no assurance that this momentum will continue. The future is uncertain and anything could happen.
2 Biotech Stocks worth buying in May Read More »
Stay updated with the latests analysis and insights fromm etfsector.com